Pure Global: EU IVD Chaos - Navigating the Last-Minute Squeeze episode artwork

EPISODE · Apr 12, 2026 · 1 MIN

Pure Global: EU IVD Chaos - Navigating the Last-Minute Squeeze

from MedTech Global Insights

In this episode of MedTech Global Insights, we dissect the immense challenges and strategic implications of the European Union's In Vitro Diagnostic Regulation (IVDR). With transition deadlines looming, a critical bottleneck in Notified Body capacity is putting thousands of products at risk of being forced off the market. We explore what this regulatory shift really means for manufacturers worldwide. We go beyond the regulations to discuss the real-world business impact. This episode covers the elevated standards for clinical evidence, the new risk-based classification system, and the strategic missteps that could cost companies their European market access. It is an essential guide for any regulatory professional, executive, or investor in the IVD space. **Case Study Spotlight:** Imagine a successful American company whose leading diagnostic test for chronic kidney disease, a market staple for over a decade, is now on the verge of being pulled from all EU clinics. Why? Their existing clinical data is no longer sufficient under IVDR, and they are stuck in a two-year queue for a Notified Body that may not approve them. Their multi-million dollar revenue stream is now in jeopardy. **This week's key takeaways:** * Why are eighty percent of all IVDs suddenly requiring Notified Body review? * What are the most common gaps in technical files that lead to rejection under IVDR? * How can you navigate the critical shortage of Notified Body availability? * Is your legacy clinical data strong enough for the new performance requirements? * What is the number one strategy proactive companies are using to secure their market share? * How does the new regulation impact your relationship with your EU Authorized Representative? * Are you prepared for the increased post-market surveillance activities IVDR mandates? * What are the hidden financial risks investors are ignoring in this transition? For more information and expert regulatory guidance, contact us at [email protected] or visit https://pureglobal.com/. For FREE AI tools and a comprehensive medical device database, visit https://pureglobal.ai/.

Episode metadata supplied by the publisher feed · Published Apr 12, 2026

Embed this episode

NOW PLAYING

Pure Global: EU IVD Chaos - Navigating the Last-Minute Squeeze

0:00 1:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MedTech Global Insights?

This episode is 1 minute long.

When was this MedTech Global Insights episode published?

This episode was published on April 12, 2026.

Can I download this MedTech Global Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!